BCG Vaccine Sales Market Share 2022: Global Trends, Key Players, Industry Analysis Report to 2028

The BCG Vaccine Sales Market size is expected to grow at an annual average of 3% during 2022-2028. The Bacillus Calmette-Guérin (BCG) vaccine is the only vaccine available to prevent tuberculosis (TB). This vaccine is usually given to children at birth in countries with high rates of tuberculosis. However, in low-risk areas, only high-risk children are usually vaccinated, whereas adults are usually not vaccinated. However, adults (age 35 and younger) who are frequently exposed to drug-resistant tuberculosis can also be vaccinated with BCG.

The following segmentation are covered in this report:

By End User

• Pediatrics
• Adults

By Usage

• Tuberculosis
• Bladder Cancer

By Drug Type

• Immune BCG
• Therapy BCG

Company Profile

• AJ Vaccines
• China National Pharmaceutical Group Corporation
• GreenSignal Bio Pharma Private Limited
• Intervax Ltd
• Japan BCG Laboratory
• Merck Sharp & Dohme Corp
• Sanofi S.A.
• Serum Institute of India Pvt Ltd
• Statens Serum Institute
• Shanghai Institute of Biological Products

Scope of the report

The research study analyses the BCG Vaccine Sales Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by BCG Vaccine Sales Market Report

• What was the BCG Vaccine Sales Market size in 2022 and 2028; what are the estimated growth trends and market forecast (2022-2028)
• What will be the CAGR of Market during the forecast period (2022-2028)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
• Which manufacturer/vendor/players in the BCG Vaccine Sales Market was the market leader in 2022?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.